Genetic variations of superoxide dismutase 2 and cytochrome P450 2E1 in non-alcoholic steatohepatitis (Q45109911)

9 December 2017

Genetic variations of superoxide dismutase 2 and cytochrome P450 2E1 in non-alcoholic steatohepatitis (English)

1 reference

non-alcoholic steatohepatitis

9 December 2017

0 references

1 reference

Yi-Shin Huang

1

1 reference

9 December 2017

Chih-Hao Chang

series ordinal

2

1 reference

9 December 2017

Tai-Ling Lin

series ordinal

3

1 reference

9 December 2017

Chin-Lin Perng

series ordinal

4

1 reference

9 December 2017

language of work or name

1 reference

4 April 2014

1 reference

9 December 2017

1 reference

9 December 2017

34

1 reference

9 December 2017

6

1 reference

9 December 2017

931-936

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

9 December 2017

1 reference

Genetics of alcoholic and nonalcoholic fatty liver disease

21 January 2018

1 reference

Manganese superoxide dismutase regulation and cancer

21 January 2018

1 reference

Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease

21 January 2018

1 reference

Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis

21 January 2018

1 reference

The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria

21 January 2018

1 reference

The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability.

21 January 2018

1 reference

Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease

21 January 2018

1 reference

Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death.

21 January 2018

1 reference

Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis

21 January 2018

1 reference

Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis

21 January 2018

1 reference

Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis

21 January 2018

1 reference

Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children

21 January 2018

1 reference

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role

21 January 2018

1 reference

CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease

21 January 2018

1 reference

Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1.

21 January 2018

1 reference

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

21 January 2018

1 reference

Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease

21 January 2018

1 reference

Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver

21 January 2018

1 reference

Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12533

1 reference

9 December 2017

1 reference